Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 23, 2010

View Archived Issues

AstraZeneca reports results from Q4 2009 and the year's R&D highlights

Alnylam initiates phase IIb trial of ALN-RSV01 in RSV-infected lung transplant patients

Curemark's CM-AT autism treatment obtains FDA fast track status

DNA prime/rAd5 boost vaccine regimen safe and immunogenic in HIV

Dual-acting NMDA antagonist neuroprotective in rat model of spinal cord injury

EnzymeRx provides clinical update on pegsitacase

Dual PI3K/mTOR inhibitor with potent preclinical antitumor activity enters phase I trial

Merck T-type calcium channel antagonists effective in models of CNS disorders

Novel HSP90 inhibitors identified by sanofi-aventis

Ranbaxy Laboratories discloses new antibacterial agents

Avexa discovers HIV integrase inhibitors for AIDS therapy

FDA approves once-daily Mirapex ER for early Parkinson's disease

PPARdelta agonists discovered at sanofi-aventis

Ceragenix and BexPharm enter into agreement for EpiCeram

Viamet and Novartis partner for metalloenzyme inhibitors

Hematopoietic prostaglandin-D2 synthase inhibitors claimed by Pfizer for asthma therapy

BioSante reports phase III LibiGel safety data

Concert Pharmaceuticals describes new GABA(A) receptor inverse agonists

GSK and FDA present safety update on Avandia for type 2 diabetes

Takeda and Affymax begin phase III trial of Hematide in chronic renal failure

FDA grants marketing approval for Gilead's Cayston for CF patients with P. aeruginosa

Amylin and Takeda to begin phase III trial of pramlintide/metreleptin in obesity

Lilly, Merck and Pfizer form Asian Cancer Research Group

Additional agents included in strategic collaboration of ExonHit and Allergan

Cyto Pulse obtains Swedish approval for phase I HIV/DNA vaccine trial

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 23, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...